Tag: Survival

Survival ranges from 24.9 percent at 22 weeks to 82.0 percent at 25 weeks; survival without severe complications varies from 6.3 to 43.2 percent

Overall, 50 face transplants have been performed worldwide

Findings seen in patients previously treated with platinum-based chemotherapy and immunotherapy whose tumors highly expressed CEACAM5

Perioperative nivolumab showed event-free survival benefit from time of surgery compared with neoadjuvant nivolumab

Stroke survivors more likely to report more than eight hours, less than seven hours, and less than six hours/night

One in five COVID-19 deaths due to strain-attributable mortality; findings were consistent across hospital types

Higher hardship seen with younger age, Medicare beneficiaries, social vulnerability and advanced disease

Each 2-point increase in Mediterranean diet score linked to significantly lower all-cause mortality

Findings for both in-hospital death and 30-day postdischarge mortality

Highest prevalence of all outcomes seen among transgender or gender-nonconforming survivors